HKPD · NASDAQ
Cellyan Biotechnology (HKPD) Stock Price & Fundamentals
Cellyan Biotechnology (HKPD) closed at $413.73 on Oct 9, 2026, up 0.07% from the previous close of $413.45.
Share price, past year
1Y +38.12%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $413.73 |
| Sep 30, 2026 | $414.28 |
| Aug 31, 2026 | $385.81 |
| Jul 31, 2026 | $376.32 |
| Jun 30, 2026 | $380.92 |
| May 29, 2026 | $362.16 |
| Apr 30, 2026 | $372.75 |
| Mar 31, 2026 | $370.38 |
| Feb 27, 2026 | $341.21 |
| Jan 30, 2026 | $342.98 |
| Dec 31, 2025 | $343.40 |
| Nov 28, 2025 | $334.50 |
| Oct 31, 2025 | $313.74 |
Key statistics
- Market cap
- —
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 16.3M
- Dividend yield
- —
- 52-week range
- $299.55 – $420.03
Market cap, P/E and dividend yield aren't shown for Cellyan Biotechnology yet: its SEC filings count its ordinary shares, which can differ from the shares traded in the US.
Financials
Cellyan Biotechnology reported revenue of $20.31M for fiscal 2025, up 21.72% from fiscal 2024.
Cellyan Biotechnology reported a net loss of $27.06K in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Mar 31, 2025 | $20.31M | +21.7% | −$27.06K | −0.1% | −$0.003 | $499.30K |
| FY2024ended Mar 31, 2024 | $16.69M | +32.9% | $1.33M | 8.0% | $0.18 | −$447.07K |
| FY2023ended Mar 31, 2023 | $12.56M | — | $998.20K | 8.0% | $0.146 | $1.61M |
Company profile
- Name
- Cellyan Biotechnology Co., Ltd
- Ticker
- HKPD
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- Headquarters
- Room B1, 5/F. Well Town Ind. Building, 13 Ko Fai Road, Yau Tong, Kowloon
- Incorporated in
- E9
- Fiscal year ends
- March
- SEC CIK
- 0002007702
Recent SEC filings
- Aug 7, 2026
- Aug 14, 2025
Frequently asked questions
What is Cellyan Biotechnology's stock price?
Cellyan Biotechnology (HKPD) closed at $413.73 on Oct 9, 2026, up 0.07% from the previous close of $413.45.
How much revenue does Cellyan Biotechnology make?
Cellyan Biotechnology reported revenue of $20.31M for fiscal 2025, up 21.72% from fiscal 2024.
Sources and methodology
Fundamentals come from Cellyan Biotechnology Co., Ltd's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures